T Yamamoto1, S Takagawa, M Kuroda, K Nishioka. Show Affiliations » 1. Department of Dermatology, Tokyo Medical and Dental University, School of Medicine, Japan.
Abstract
Entities: Chemical Disease Gene
Mesh: See more » AnimalsBleomycinFemaleHydroxyproline/antagonists & inhibitorsHydroxyproline/metabolismInterferon-gamma/therapeutic useMiceMice, Inbred BALB CPulmonary Fibrosis/chemically inducedPulmonary Fibrosis/drug therapyPulmonary Fibrosis/pathologyScleroderma, Systemic/chemically inducedScleroderma, Systemic/drug therapyScleroderma, Systemic/metabolismScleroderma, Systemic/pathologySkin/metabolismSkin/pathology
Substances: See more » BleomycinInterferon-gammaHydroxyproline
Year: 2000 PMID: 10966061 DOI: 10.1007/s004030000136
Source DB: PubMed Journal: Arch Dermatol Res ISSN: 0340-3696 Impact factor: 3.017